INTERVACC AB has a total of 19 patent applications. Its first patent ever was published in 2006. It filed its patents most often in EPO (European Patent Office), Australia and United States. Its main competitors in its focus markets pharmaceuticals and biotechnology are ANTISOMA LTD, SYNTHON BIOPHARMACEUTICALS BV and PROTOX THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Australia | 3 | |
#3 | United States | 3 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | Hong Kong | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Guss Bengt | 17 |
#2 | Frykberg Lars | 17 |
#3 | Flock Margareta | 17 |
#4 | Flock Jan-Ingmar | 17 |
#5 | Zachrisson Karl Olov | 3 |
#6 | Flock Jan-Ingmar J-I | 1 |
#7 | Bergman Rune | 1 |
#8 | Frykberg Lars L | 1 |
#9 | Janzon Kenneth | 1 |
#10 | Flock Margareta M | 1 |
Publication | Filing date | Title |
---|---|---|
EP3319630A1 | Vaccine against s.suis infection | |
AU2013205101A1 | Improved immunizing composition | |
NZ586367A | Improved immunizing composition comprising an antigen from Streptococcus equi |